MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism
MDMX is overexpressed in the vast majority of patients with acute myeloid leukemia (AML). We report that MDMX overexpression increases preleukemic stem cell (pre-LSC) number and competitive advantage. Utilizing five newly generated murine models, we found that MDMX overexpression triggers progressio...
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Cell Press
2021
|